UAB "Via pharma" Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 49,866 |
| 14,975 |
| -19,824 |
| -19,824 |
| -5,953 |
| 37.54 |
| -39.75 |
| 75,338 |
| 60,661 |
| 1 |
| 135,998 |
| 2024 |
|---|
| 75,983 |
| 18,996 |
| -51,473 |
| -51,473 |
| -12,868 |
| -11.79 |
| -67.74 |
| 23,865 |
| 62,021 |
| 1 |
| 85,885 |
| 2025 |
|---|
| 236,537 |
| 59,134 |
| -9,192 |
| -9,192 |
| -2,298 |
| 12.57 |
| -3.89 |
| 14,674 |
| 194,696 |
| 1 |
| 209,369 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 236,537 |
| 59,134 |
| -9,192 |
| -9,192 |
| -2,298 |
| 12.57 |
| -3.89 |
| 14,674 |
| 194,696 |
| 1 |
| 209,369 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
236,537 €211 % *
Sales per employee (€)
59,134 €211 % *
Profit before tax (€)
-9,192 €82 % *
Net Profit (€)
-9,192 €82 % *
Profit per employee (€)
-2,298 €82 % *
Total profitability (%)
12.57 %206.62 % *
Net profitability (%)
-3.89 %94.26 % *
Equity (€)
14,674 €-39 % *
Amounts Payable And Liabilities (€)
194,696 €214 % *
Non-current Assets (€)
1 €0 % *
CurrentAssets (€)
209,369 €144 % *
